Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Averting inflammation by targeting the cytokine environment.
Incidence and prevalence of multiple sclerosis in southeastern Iran.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Charcot-Marie-Tooth Disease Type 4H Resulting from Compound Heterozygous Mutations in FGD4 from Nonconsanguineous Korean Families.
The dynamics of finger tremor in multiple sclerosis is affected by whole body position.
Home-Based Balance Training Using the Wii Balance Board: A Randomized, Crossover Pilot Study in Multiple Sclerosis.
Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Epidemiology in multiple sclerosis: a pilgrim's progress.
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Optical coherence tomography and its use in optical neuritis and multiple sclerosis.
Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.
Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin.
T Cell-Intrinsic Function of the Noncanonical NF-κB Pathway in the Regulation of GM-CSF Expression and Experimental Autoimmune Encephalomyelitis Pathogenesis.
Bispecificity for Myelin and Neuronal Self-Antigens Is a Common Feature of CD4 T Cells in C57BL/6 Mice.
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.
Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency.
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Dimethyl fumarate - only an anti-psoriatic medication?
Pages
« first
‹ previous
…
234
235
236
237
238
239
240
241
242
…
next ›
last »